DCF FV=$95 vs current $35.90 — model shows massive upside (P(above)=99.5%). IP is in the middle of a transformation (spinning off Sylvamo, packaging pivot). No earnings currently which limits analysis. Below 200dma — momentum against. No near-term catalyst identified. Neutral/watch: compelling DCF but operational transformation risk and negative momentum keep me from committing. Upgrading from 5 to 6.
Fair Value Distribution — percentile bands
100.0% of simulations place fair value above current price
WHAT IS PRICED IN
Revenue-Based Reverse DCF
-3.3%/yr
±5.2% · revenue growth to justify current price
FCF-Based Reverse DCF
-13.3%/yr
±2.1% · FCF growth to justify current price
THE GAP
Market pricing margin expansion or capex normalization
KEY VALUE DRIVERS
Spearman correlation — what moves this valuation most
Eagle will generate this view by the next trading session (~6h).
Eagle will generate this view by the next trading session (~6h).
Portfolio-focused packaging pure-play post-DS Smith acquisition. Major EMEA separation catalyst (late 2026/early 2027). Divested non-core Cellulose Fibers (.5B). Restructuring initiatives ongoing. Pos...